FDA
-
-
-
-
-
-
-
Humacyte, Inc. Announces Proposed Public Offering of Common Stock
-
-
-
-
-
-
-
Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access
-
-
-
-
-
-
-
Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026
-
-
-
-
-
-
-
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Humacyte raises $20 million in registered direct offering
-
-
-
-
-
-
-
BTIG Reiterates Buy Rating on Humacyte (HUMA)
-
-
-
-
-
-
-
Humacyte secures $77.5 million credit facility with Avenue Capital
-
323,592 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

